Early VC Outreach: Why Founders of Successful Biotech and MedTech Startups Don’t Wait

In 2024, global venture capital funding in biotech hit $21.4B, surging by almost 33% compared to 2023 and surpassing pre-pandemic levels. This is a clear signal to all biotech companies: Venture capit...